Prior to a cannabinoid product other than a cannabinoid edible, topical, tincture or capsule being sold or transferred to a consumer, patient or designated primary caregiver, the container holding the product must have a label that has the following information:

1. (1) Processor’s business or trade name and license number.
2. (2) Business or trade name and license number for the licensee that packaged the product, if different from the processor.
3. (3) Product identity.
4. (4) UID number.
5. (5) Date the product was made.
6. (6) Net weight or volume in U.S. customary and metric units.
7. (7) Serving size and number of servings per container.
8. (8) Amount, in milligrams, of THC and CBD in each serving and in the container.
9. (9) List of all ingredients in descending order of predominance by weight or volume used to process the cannabinoid product.
10. (10) Name of the lab that performed any test and any test analysis date.
11. (11) Universal symbol.
12. (12) Activation time expressed in words or through a pictogram.
13. (13) A statement that reads: “This product is not approved by the FDA to treat, cure, or prevent any disease.”

14. (14) For cannabinoid products for sale to a consumer, warnings that state:

    1. (a) “For use only by adults 21 and older. Keep out of reach of children.”
    2. (b) “Do not drive a motor vehicle while under the influence of marijuana.”
    3. (c) “DO NOT EAT” in bold, capital letters.

15. (15) For medical grade cannabinoid products for use by a patient, the medical grade symbol and medical warnings that state:

    1. (a) “For use by OMMP patients only. Keep out of reach of children.”
    2. (b) “Do not drive a motor vehicle while under the influence of marijuana.”
    3. (c) “DO NOT EAT” in bold, capital letters.

16. (16) For inhalable cannabinoid products that contain non-cannabis additives:

    1. (a) The product identity must clearly identify that the product contains non-cannabis additives and, in addition to the other requirements of OAR 845-025-7000 through 845-025-7190, must include the words “non-cannabis additive.”
    2. (b) In addition to the other ingredients in the inhalable cannabinoid product, for each non-cannabis additive used, the ingredient listing must contain the words “non-cannabis additive” in a manner that clearly distinguishes each additive from any other additives.

    3. (c) All of the ingredients in the non-cannabis additive:

       1. (A) Must match the ingredients identified on the list of ingredients required by OAR 845-025-3265(1);
       2. (B) Must be listed either alphabetically or in descending order of predominance by weight or volume; and

       3. (C) Must be listed on:

          1. (i) The label’s ingredient list as sub-ingredients of the ingredient term “non-cannabis additive”; or
          2. (ii) An insert within the product’s container that clearly indicates that the ingredients listed are contained within the inhalable cannabinoid product.

Statutory/Other Authority

ORS 475C.604, 475C.233 & 475C.237

Statutes/Other Implemented

ORS 475C.604

History

OLCC 6-2025, amend filed 11/20/2025, effective 01/01/2026
OLCC 154-2022, minor correction filed 03/25/2022, effective 03/25/2022
OLCC 24-2020, amend filed 12/21/2020, effective 12/22/2020
OLCC 6-2018, adopt filed 05/23/2018, effective 06/01/2018